Co-Authors
This is a "connection" page, showing publications co-authored by DANIEL GLAZE and DAVUT PEHLIVAN.
Connection Strength
1.593
-
Comprehensive assessment reveals numerous clinical and neurophysiological differences between MECP2-allelic disorders. Ann Clin Transl Neurol. 2025 Feb; 12(2):433-447.
Score: 0.247
-
Structural variant allelic heterogeneity in MECP2 duplication syndrome provides insight into clinical severity and variability of disease expression. Genome Med. 2024 Dec 18; 16(1):146.
Score: 0.245
-
Development and validation of parent-reported gastrointestinal health scale in MECP2 duplication syndrome. Orphanet J Rare Dis. 2024 Feb 09; 19(1):52.
Score: 0.231
-
Exploring gastrointestinal health in MECP2 duplication syndrome. Neurogastroenterol Motil. 2023 08; 35(8):e14601.
Score: 0.219
-
Exploring the characteristics and most bothersome symptoms in MECP2 duplication syndrome to pave the path toward developing parent-oriented outcome measures. Mol Genet Genomic Med. 2022 08; 10(8):e1989.
Score: 0.206
-
Assessing the Burden on Caregivers of MECP2 Duplication Syndrome. Pediatr Neurol. 2022 08; 133:1-8.
Score: 0.205
-
Gastrointestinal Health Questionnaire for Rett Syndrome: Tool Development. J Pediatr Gastroenterol Nutr. 2021 03 01; 72(3):354-360.
Score: 0.189
-
New-Onset Diabetes Presenting With Hyperosmolar Hyperglycemic State in a Lean Adolescent With Atypical Rett Syndrome Using Antipsychotics. Clin Diabetes. 2022; 40(4):503-507.
Score: 0.050